Fingerprint
Dive into the research topics of 'Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Steven A. Narod, Marie Pierre Dubé, Jan Klijn, Jan Lubinski, Henry T. Lynch, Parviz Ghadirian, Daine Provencher, Ketil Heimdal, Pal Moller, Mark Robson, Kenneth Offit, Claudine Isaacs, Barbara Weber, Eitan Friedman, Ruth Gershoni-Baruch, Gad Rennert, Barbara Pasini, Theresa Wagner, Mary Daly, Judy E. Garber
- University of Toronto
- Erasmus University Rotterdam
- Pomeranian Medical University in Szczecin
- Creighton University
- Centre Hospitalier de l’Université de Montréal Research Center
- Hôpital Notre-Dame
- University of Oslo
- Memorial Sloan-Kettering Cancer Center
- Georgetown University
- University of Pennsylvania
- Sheba Medical Center at Tel Hashomer
- Rambam Health Care Campus Israel
- Clalit Health Services
- Fondazione IRCCS Istituto Nazionale dei Tumori
- University of Vienna
- Dana-Farber Cancer Institute
- University of Utah
- London Regional Cancer Center
- Lund University
- Imperial College Healthcare NHS Trust
- Strang Cancer Prevention Center
- McGill University
- Sunnybrook Health Sciences Centre
- British Columbia Cancer Agency
- University of Chicago
- Beth Israel Deaconess Medical Center
- Cincinnati Children's Hospital Medical Center
- City of Hope National Medical Center
- University of Michigan, Ann Arbor
- Institut Curie
Research output: Contribution to journal › Article › peer-review
339
Scopus
citations